Evidence map›Paper›PMID 25568442›Full record

ArticleJournal of clinical microbiology2015

Studying Bordetella pertussis populations by use of SNPeX, a simple high-throughput single nucleotide polymorphism typing method.

Anne Zeddeman, Sandra Witteveen, Marieke J Bart, Marjolein van Gent, Han G J van der Heide, Kees J Heuvelman, Leo M Schouls, Frits R Mooi

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Evolution of Bordetella pertussis in the acellular vaccine era in Norway, 1996 to 2019.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2022
    Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Anne ZeddemanCentre for Infectious Disease Control (CIb), National Institute of Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Sandra WitteveenCentre for Infectious Disease Control (CIb), National Institute of Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Marieke J BartCentre for Infectious Disease Control (CIb), National Institute of Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Marjolein van GentCentre for Infectious Disease Control (CIb), National Institute of Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Han G J van der HeideCentre for Infectious Disease Control (CIb), National Institute of Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Kees J HeuvelmanCentre for Infectious Disease Control (CIb), National Institute of Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Leo M SchoulsCentre for Infectious Disease Control (CIb), National Institute of Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Frits R MooiCentre for Infectious Disease Control (CIb), National Institute of Public Health and the Environment (RIVM), Bilthoven, the Netherlands frits.mooi@rivm.nl.
National Institute for Public Health and the Environment · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Large outbreaks of pertussis occur despite vaccination. A first step in the analyses of outbreaks is strain typing. However, the typing of Bordetella pertussis, the causative agent of pertussis, is problematic because the available assays are insufficiently discriminatory, not unequivocal, time-consuming, and/or costly. Here, we describe a single nucleotide primer extension assay for the study of B. pertussis populations, SNPeX (single nucleotide primer extension), which addresses these problems. The assay is based on the incorporation of fluorescently labeled dideoxynucleotides (ddNTPs) at the 3' end of allele-specific poly(A)-tailed primers and subsequent analysis with a capillary DNA analyzer. Each single nucleotide polymorphism (SNP) primer has a specific length, and as a result, up to 20 SNPs can be determined in one SNPeX reaction. Importantly, PCR amplification of target DNA is not required. We selected 38 SNPeX targets from the whole-genome sequencing data of 74 B. pertussis strains collected from across the world. The SNPeX-based phylogenetic trees preserved the general tree topology of B. pertussis populations based on whole-genome sequencing, with a minor loss of details. We envisage a strategy whereby SNP types (SnpTs) are quickly identified with the SNPeX assay during an outbreak, followed by whole-genome sequencing (WGS) of a limited number of isolates representing predominant SnpTs and the incorporation of novel SNPs in the SNPeX assay. The flexibility of the SNPeX assay allows the method to evolve along with the pathogen, making it a promising method for studying outbreaks of B. pertussis and other pathogens.

Indexed as

Polymorphism, Single NucleotideBordetella pertussisGenotyping TechniquesHigh-Throughput Screening AssaysHumansMolecular EpidemiologyWhooping Cough

Identifiers

PMID25568442
PMCPMC4390674
OpenAlexW2168971780

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.